The pattern electroretinogram in patients with optic nerve disease

Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis

The pattern electroretinogram (PERG) provides an objective measure of central retinal function, and has become an important element of the author's clinical visual electrophysiological practice. The PERG contains two main components, a positivity at approximately 50ms (P50) and a larger negativity at approximately 95ms (N95). The P50 component is affected by macular dysfunction with concomitant reduction in N95. The PERG therefore complements the Ganzfeld ERG in the assessment of patients with retinal disease. In contrast, the ganglion cell origins of the N95 component allow electrophysiological evaluation of ganglion cell function both in primary disease and in dysfunction secondary to optic nerve disease, where selective loss of N95 can be observed. Both macular dysfunction and optic nerve disease can give abnormalities in the visual evoked cortical potential (VEP), and the PERG thus facilitates more meaningful VEP interpretation. This review addresses the origins and recording of the PERG, and then draws on extensive clinical data from patients with genetically determined retinal and macular dystrophies, other retinal diseases and a variety of optic nerve disorders, to present an integrated approach to diagnosis.

Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations in vision

Contrast sensitivity testing, in common with color vision (another test of psychophysical function), demonstrates significant changes in diabetic subjects compared with nondiabetic controls, and there is some evidence for a relationship with grade of retinopathy. Changes in contrast sensitivity have been demonstrated in children and adults with diabetes of short duration, and some evidence exists for a correlation with poor glycemic control, although prospective studies are required to assess this relationship over a longer time period. Although both color vision and contrast sensitivity demonstrate similar patterns, studies that directly compare the two tests suggest that measurement of contrast sensitivity is the more sensitive and specific.

The pattern electroretinogram in anterior visual pathway dysfunction and its relationship to the pattern visual evoked potential: a personal clinical review of 743 eyes

The pattern electroretinogram (PERG) has now been in routine clinical use for sufficiently long to allow a personal clinical review of its relationship to the cortically generated pattern visual evoked potential (PVEP). The PERG and PVEP findings are presented from 520 eyes with optic nerve demyelination (382 eyes), optic nerve compression (90 eyes) or heredofamilial optic atrophy (48 eyes), and these are compared with the findings obtained in 223 eyes with dysfunction anterior to the retinal ganglion cells. Dysfunction anterior to the retinal ganglion cells gives a reduction in the P50 component of the PERG, but this component is usually spared in optic nerve disease where selective loss of the N95 component is by far the most frequently occurring abnormality. A diagnostic strategy is presented.

Electrophysiological methods in early glaucoma detection

Electrophysiological methods like pattern electroretinogram and pattern visual evoked potentials may be the best approach for early glaucoma detection, as they have demonstrated to be sensitive to the ganglion cells functional changes. Reported values of both P50 and N95 pattern electroretinogram components differ widely, a fact perhaps related to a heterogeneous grouping of patients suffering from ocular hypertension and glaucoma, rather than to the type of technique utilized. This study is based on a total of 42 subjects: 14 normals, 16 subjects suffering from ocular hypertension, and 12 patients with glaucoma, with 79 eyes examined. Pattern electroretinogram and pattern visual evoked potentials were used as successive techniques. Setting condition for pattern electroretinogram, such as low temporal frequency (2 Hz), 30 min check size, high contrast (99%) and luminance (93 cd/m2), identified the N95 component as the best index for early glaucoma detection. In the control group N95 mean amplitude was 1.62 muV +/- 0.59 SD and showed almost significant difference with ocular hypertension (p = 0.07) and highly significant difference with the glaucoma group (p < 0.01), with decrement of 58.6% in the glaucoma group. P50 mean amplitude, on the contrary, did not show significant differences among the groups (Newman-Keul test), its reduction in glaucoma being 28%. The mean pattern visual evoked potentials latency was alos highly significant between glaucoma and control groups, but not between ocular hypertension and control groups; the mean amplitude did not show significant differences. A proportion of 26.6% abnormal pattern electroretinogram was found in the group suspected of having glaucoma where conventional methods had proved normal.(ABSTRACT TRUNCATED AT 250 WORDS)

The incidence of abnormal pattern electroretinography in optic nerve demyelination

This report describes the pattern electroretinogram (PERG) findings in 141 patients with optic nerve demyelination in one or both eyes. The overall incidence of PERG abnormality in the 199 eyes with abnormally delayed pattern visual evoked potential (PVEP) P100 component was 39.2%, with 84.6% of these PERG abnormalities being confined to the N95 component. The incidence of abnormal PERG was greater (53.3%) in those eyes with a history of retrobulbar neuritis than in those with sub-clinical demyelination (22.8%). The importance of stimulus parameters is noted. The value of the PERG in the improved interpretation of an abnormal PVEP is discussed.

Pattern electroretinography in patients with delayed pattern visual evoked potentials due to distal anterior visual pathway dysfunction

Between March 1983 and January 1988 delayed pattern visual evoked potentials (PVEP) were observed in 67 patients with distal visual pathway dysfunction. Many of these patients had been referred for neurophysiological examination because of possible optic nerve dysfunction. These patients also had pattern electroretinography (PERG) performed which in all cases showed an abnormality of the main positive P50 component. None of these patients had an abnormality confined to the negative N95 component, the type of abnormality usually found if the PERG is abnormal in optic nerve disease. It is suggested that PERG recording should now be a routine adjunct to the PVEP in the assessment of anterior visual pathway dysfunction.

A review of the clinical applications of the pattern electroretinogram

The pattern electroretinogram (PERG) has recently been introduced as a clinical procedure. It has been thought by many to represent activity of the retinal ganglion cells, although this is still a matter of contention. The exciting prospect of a selective test of ganglion cell function led to the application of the PERG in a variety of ophthalmological conditions. In the course of these investigations the PERG was found to be diminished in cases of maculopathy, optic atrophy, optic neuritis, toxic optic neuropathy, neurotransmitter disorders, glaucoma and ocular hypertension and in retinal vascular disorders such as diabetes. It was also affected in some cases of amblyopia. This paper briefly describes the techniques used to record the PERG and reviews current literature pertaining to its clinical application.

The pattern electroretinogram

Physiological experiments and the exploitation of clinical conditions have provided compelling evidence that retinal ganglion cells and other inner retinal structures generate the pattern ERG (PERG). As an increasing number of clinical reports have been published some contradictory findings have been reported. These may be ascribed to variation in recording and measuring techniques. The PERG consists of two major portions, the early positive and the following negative component which can be investigated separately if the stimulus conditions allow isolated (or "transient") responses to be recorded. Care has to be taken in positioning the reference electrode, maintaining accurate refraction, and the influence of pupil size must be considered. Furthermore the PERG is contaminated by a luminance component which may be generated in the outer retina. The size of this increases with low spatial frequency (large check-sizes) and high mean luminance. The PERG permits the examination of an additional level of the retina and helps the understanding of pathophysiology of various eye diseases, and is of clinical importance in routine diagnosis and assessment. In glaucoma the PERG amplitude is often reduced before it is possible to detect a scotoma and it is therefore an important prognostic indicator in patients with ocular hypertension. In diabetic retinopathy, retinal ischaemia sufficient to lead to the pre-proliferative state can be demonstrated. The PERG also has a major clinical role in examining localised retinal pathology. If combined with VECP recording, it greatly extends the interpretations possible, since not only can damage to the optic nerve be detected by both tests, but the normal PERG in the presence of an abnormal PVECP implies that the losses are confined to the central pathway.

Significance of abnormal pattern electroretinography in anterior visual pathway dysfunction

The pattern electroretinogram (PERG) findings in 72 patients with disease of the anterior visual pathways are presented in relation to the site of dysfunction. Two components of the PERG are described which are selectively involved in different pathologies. In particular, the main positive P50 component is invariably affected in retinal/macular dysfunction, whereas the late negative N95 component is principally affected in optic nerve disease.